Your browser doesn't support javascript.
loading
A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients.
Escalante, Carmen P; Meyers, Christina; Reuben, James M; Wang, Xuemei; Qiao, Wei; Manzullo, Ellen; Alvarez, Ricardo H; Morrow, Phuong Khanh; Gonzalez-Angulo, Ana M; Wang, Xin Shelley; Mendoza, Tito; Liu, Wenli; Holmes, Holly; Hwang, Jessica; Pisters, Katherine; Overman, Michael; Cleeland, Charles.
Afiliação
  • Escalante CP; From the *The University of Texas MD Anderson Cancer Center, Houston, TX; and †Hematology/Oncology Therapeutic Area, Amgen, Thousand Oaks, CA.
Cancer J ; 20(1): 8-14, 2014.
Article em En | MEDLINE | ID: mdl-24445757

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fadiga / Metilfenidato / Neoplasias Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fadiga / Metilfenidato / Neoplasias Idioma: En Ano de publicação: 2014 Tipo de documento: Article